The Structural Enablers of the Current Cycle

The M&A market's recovery from the 2022-2023 freeze has been one of the defining stories of capital markets over the past two years. After a period in which rising interest rates, regulatory uncertainty, and bid-ask spread divergence between buyers and sellers effectively suspended large portions of the deal market, the conditions for a genuine recovery have now aligned.

Global M&A volumes rebounded to $4.4 trillion in 2025, fuelled by a concentration of large deals in the final quarter of the year. Twenty-two of the seventy global transactions with values above $10 billion were executed in Q4 2025 alone a pattern that suggests pent-up demand rather than organic pace. North American deal value exceeded $1.1 trillion in Q4, while European M&A recorded a 25% increase in the same period.

Several distinct forces are converging to drive M&A activity in 2026.

Deregulation and Antitrust Repositioning

The shift in US antitrust enforcement posture under the Trump administration has been one of the most material changes to the M&A environment in recent years. The replacement of aggressive merger enforcement officials with appointees who favour a more permissive, market-oriented approach has materially reduced the regulatory risk that caused many transactions to be abandoned or restructured in 2022-2024. Approximately 40% of the S&P 500's market capitalisation had transactions under investigation or review at various points during the peak enforcement period.

Corporate Balance Sheets and Strategic Imperatives

Corporate balance sheets across the US and much of Europe are in good shape. The earnings recovery of 2023-2025 has rebuilt cash generation, reduced leverage ratios in most sectors, and restored management confidence to contemplate transformative rather than merely defensive transactions.

Private Equity Dry Powder

PE firms are sitting on near-record levels of uncommitted capital dry powder estimated at approximately $2.5-3 trillion globally. The deployment of this capital requires transactions; transactions require exit markets; and exit markets require M&A and IPO activity. The reinforcing dynamic between PE deal activity and M&A markets creates a positive feedback loop: as exits become available, LPs receive distributions, LPs recommit capital, PE managers raise new funds, and new capital needs to be deployed.

Improving Debt Market Conditions

The decline in short-term interest rates the Fed cutting toward 3%, ECB cutting toward 2% has reduced the cost of acquisition financing. The leveraged loan and high-yield bond markets are functioning well; the broadly syndicated loan market has re-engaged alongside private credit, providing multiple financing options for leveraged transactions.

Compressed Bid-Ask Spreads

The fundamental reason for the 2022-2023 deal freeze was not a lack of desire to transact it was an inability to agree on price. Sellers had priced their assets at 2021 multiples; buyers, facing higher financing costs and lower public market comps, could not support those prices. The resolution has come through a combination of sellers accepting mark-to-market reality and buyers gaining confidence that stabilising interest rates and improving earnings make transaction economics viable at current prices.

Sector-by-Sector Deal Flow Map

The deal activity is not uniformly distributed. A sector-by-sector analysis reveals where the most compelling strategic and financial rationales are concentrated.

Technology and AI

The most active sector for strategic M&A, driven by both the urgency of AI capability acquisition and the consolidation pressure facing mid-sized software companies. Transactions in this sector include: hyperscalers acquiring AI startup capabilities; enterprise software companies consolidating to achieve scale and cross-sell opportunity; and infrastructure companies (data centres, networking, cooling systems) consolidating fragmented markets.

Healthcare and Life Sciences

The patent cliff of 2028-2029 is creating a compelling and time-sensitive M&A rationale for large pharmaceutical companies. With significant branded drug revenues at risk from generic competition, acquirers are actively seeking pipeline-stage biotechs and specialty pharmaceutical businesses to replace cash flows and extend growth profiles. The therapeutic areas commanding the highest M&A premium are inflammation and immunology, oncology, and cardiometabolic conditions.

Financial Services

Deregulation in US financial services is directly enabling bank consolidation that was constrained under the previous regulatory environment. Mid-size US banks are candidates for consolidation both through acquisition by larger peers and through mergers among themselves to achieve the scale required to compete in technology investment and regulatory compliance cost absorption.

Energy and Infrastructure

The energy transition is generating M&A activity across multiple sub-sectors. Traditional energy companies are acquiring renewable assets; utilities are consolidating to finance the grid infrastructure required for electrification; and energy technology companies are being acquired by strategic buyers seeking to position for a multi-decade transition.

Industrials and Defence

Rearming and reshoring are creating M&A demand in industrials. Defence prime contractors are acquiring technology and electronic warfare specialists. Aerospace MRO companies are consolidating. Domestic manufacturing businesses with strategic value in a supply chain reshoring context are attracting acquisition interest from PE firms and strategic buyers simultaneously.

Mid-Market: The Volume Story

While mega-deals capture the headline commentary, the volume of M&A activity is predominantly a mid-market story. In a Citizens Financial survey of approximately 400 mid-market firms, 58% of executives expect M&A volumes to climb in 2026. This sentiment is supported by improving financing conditions, normalised valuations after several years of private market repricing, and the strategic logic of consolidation in fragmented industries.

For advisory firms focused on mid-market transactions the $50 million to $1 billion deal size range the pipeline is genuinely strong. PE firms are more engaged on mid-market acquisitions where competition is less intense and operational value creation is a more direct driver of return. Corporate carve-outs large conglomerates divesting non-core businesses to focus on core capabilities are creating a stream of well-defined, often profitable businesses that meet the return profile PE buyers require.

The Risks That Could Interrupt the Cycle

Balanced analysis requires equal attention to the risks. The M&A recovery is real, but it rests on conditions that could deteriorate.

The M&A cycle of 2026 is real, well-supported, and likely to produce aggregate volumes that approach or exceed the 2021 peak. The structural enablers deregulation, PE dry powder, improving financing conditions, corporate balance sheet strength, and CEO confidence are in place.

Conclusion

The risks are present but not dominant. They are the risks of any mature phase of a capital market cycle: complacency about execution, sensitivity to financing market disruption, and the political uncertainty inherent in an election year. Investors and advisors who maintain analytical discipline who ask whether the strategic logic of a transaction stands independently of the enabling conditions, whether the price paid makes sense across a range of macro scenarios, and whether execution risk is being adequately assessed will navigate the cycle better than those who are carried by momentum.

This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. The views expressed are those of Brenton Research and are subject to change without notice. Brenton Financial Pty Ltd (ABN 21 696 298 227). Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal.